Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

See Remarks

Chief Business Officer

Executive Chairman and CEO

Alpine Immune Sciences, Inc., a clinical-stage company, focuses on immune therapeutics. The company has strategic collaborations immunotherapies via protein engineering technologies with biopharmaceutical companies and has a pipeline of clinical and preclinical candidates in development. Its pipeline includes Povetacicept (ALPN-303), which is in a phase 1b, open-label study of povetacicept in autoimmune cytopenias, including immune thrombocytopenia, warm autoimmune hemolytic anemia, and cold agglutinin disease; and in phase 1b/2a, open-label study of povetacicept in autoimmune glomerulonephritis, including IgA nephropathy, lupus nephritis, and primary membranous nephropathy. The company is also developing Acazicolcept (ALPN-101), which is in a phase 2 study of acazicolcept in patients with Systemic Lupus Erythematosus. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

Alpine Immune Sciences, Inc., a clinical-stage company, focuses on immune therapeutics.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-25	Premium	sold	Premium	Premium	Premium	-
2024-04-25	Premium	acquired	Premium	Premium	Premium	-
2024-01-26	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-26	Premium	sold	Premium	Premium	Premium	See Remarks
2024-01-25	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-25	Premium	sold	Premium	Premium	Premium	See Remarks
2024-01-18	Premium	acquired	Premium	Premium	Premium	-
2024-01-18	Premium	acquired	Premium	Premium	Premium	-
2024-01-11	Premium	acquired	Premium	Premium	Premium	-
2024-01-11	Premium	acquired	Premium	Premium	Premium	-
2024-01-04	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2024-01-04	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-04	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-04	Premium	acquired	Premium	Premium	Premium	Executive Chairman and CEO
2023-12-28	Premium	acquired	Premium	Premium	Premium	Executive Chairman and CEO
2023-12-28	Premium	sold	Premium	Premium	Premium	Executive Chairman and CEO
2023-12-28	Premium	sold (taxes)	Premium	Premium	Premium	Executive Chairman and CEO
2023-12-28	Premium	acquired	Premium	Premium	Premium	Executive Chairman and CEO
2023-12-28	Premium	sold	Premium	Premium	Premium	-
2023-12-28	Premium	sold	Premium	Premium	Premium	-
2023-12-27	Premium	sold	Premium	Premium	Premium	Executive Chairman and CEO
2023-12-27	Premium	sold	Premium	Premium	Premium	-
2023-12-27	Premium	acquired	Premium	Premium	Premium	Executive Chairman and CEO
2023-12-27	Premium	sold	Premium	Premium	Premium	-
2023-12-26	Premium	acquired	Premium	Premium	Premium	Executive Chairman and CEO

ALPN - Alpine Immune Sciences Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ALPN